Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study.
Aoki T, Kagawa N, Sugiyama K, Wakabayashi T, Arakawa Y, Yamaguchi S, Tanaka S, Ishikawa E, Muragaki Y, Nagane M, Nakada M, Suehiro S, Hata N, Kuroda J, Narita Y, Sonoda Y, Iwadate Y, Natsumeda M, Nakazato Y, Minami H, Hirata Y, Hagihara S, Nishikawa R.
Aoki T, et al. Among authors: kuroda j.
Int J Clin Oncol. 2021 Dec;26(12):2205-2215. doi: 10.1007/s10147-021-02028-1. Epub 2021 Sep 29.
Int J Clin Oncol. 2021.
PMID: 34586548
Free PMC article.